Episurf Medical plans to launch products in Poland, beginning with Episealer® knee implants. Product registration is in final phases for distribution through a local partner.
The company estimates that 10,000 to 15,000 knee replacement surgeries performed annually in the region.
Episealer personalized implants and Epiguide® surgical drill guides are designed to treat localized cartilage injury in joints. Within 2018, the company has filed its Investigational Device Exemption with FDA to initiate a U.S. study of Episealer, and expanded its distribution to include Hong Kong and Spain
Source: Episurf Medical